StrataGraft (Stratatech)

N/A

Report date: 2024/01/25 11:31:00

Base Information

Drug NameStrataGraft (Stratatech)
Drug Alias Nameallogeneic cultured keratinocytes and dermal fibroblasts in murine collagen- dsatStrataGraft
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Keratinocytes therapyCell and gene therapy > Cell therapy > Somatic cell > Dermal fibroblasts therapyCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionTissue replacements
TargetsNot applicable
Therapy Area/IndicationsDegloving InjuriesBurnsWounds and Injuries +[4] 
Global Approved IndicationsBurns
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/06/15
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin SystemWisconsin Alumni Research FoundationMallinckrodt
China Registration ClassN/A

Develop Information

Active CompaniesStratatech Corp
Inactive CompaniesWisconsin Alumni Research FoundationUniversity Of Wisconsin SystemMallinckrodt
Active IndicationsBurns
Inactive IndicationsDegloving InjuriesWounds and InjuriesWound Infection

Other Information

ATC CodeN/A
Related LinksN/A